Aeterna Zentaris Inc. Shares Fall 2.2% Below Previous 52-Week Low - Market Mover
The shares fell 2.2% lower than its previous 52-week low of $0.38, with trading volume higher than its 30 day average
Dec 30, 2021 by Kwhen Finance Editors
Aeterna Zentaris Inc. (AEZS) shares closed 2.2% lower than its previous 52 week low, giving the company a market cap of $46M. The stock is currently down 10.7% year-to-date, down 11.2% over the past 12 months, and down 89.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%.
Trading Activity
- Trading volume this week was 86.6% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | -2.6 | -10.7 | -11.2 | -89.5 | 0.4 |
| Dow Jones Industrial Average | 0.2 | 21.0 | 21.8 | -0.3 | 23.9 |
| S&P 500 Index | 0.1 | 29.2 | 29.8 | -0.4 | 32.5 |
| Health Care | 0.6 | 23.0 | 24.6 | -0.8 | 26.8 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 6.5%
- The company's stock price performance over the past 12 months lags the peer average by 27.6%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Aeterna Zentaris Inc. | AEZS | 0 | -10.7 | -11.2 | -89.5 | 0.4 |
| Peer Avg | N/A | 5.6 | -10.0 | -8.8 | -20.7 | 12.2 |
| Novartis AG - ADR | NVS | 37.2 | -2.9 | 0.5 | -7.8 | 10.5 |
| Bristol-Myers Squibb Co. | BMY | -25.6 | 2.9 | 5.2 | -10.1 | 16.9 |
| Sanofi - ADR | SNY | 8.4 | 7.2 | 8.7 | -7.3 | 15.6 |
| Halozyme Therapeutics Inc. | HALO | 13.8 | -6.4 | -5.1 | -29.1 | 25.8 |
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -61.0 | -62.1 | -70.0 | 4.6 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: